| NDC Code | 81968-045-31 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (81968-045-31) / 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE |
|---|
| Product NDC | 81968-045 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Auvelity |
|---|
| Non-Proprietary Name | Dextromethorphan Hydrobromide, Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, MULTILAYER, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20220818 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA215430 |
|---|
| Manufacturer | Axsome Therapeutics, Inc. |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE |
|---|
| Strength | 105; 45 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
|---|